Alcoholic and Nonalcoholic Fatty Liver Disease and Incident Hospitalization for Liver and Cardiovascular Diseases

Matteoni, 1999, Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity, Gastroenterology, 116, 1413, 10.1016/S0016-5085(99)70506-8 Chalasani, 2012, The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology, Gastroenterology, 142, 1592, 10.1053/j.gastro.2012.04.001 Rehm, 2013, Global burden of alcoholic liver diseases, J Hepatol, 59, 160, 10.1016/j.jhep.2013.03.007 Mills, 2005, Comparison of the natural history of alcoholic and nonalcoholic fatty liver disease, Curr Gastroenterol Rep, 7, 32, 10.1007/s11894-005-0063-4 Younossi, 2016, Contribution of alcoholic and nonalcoholic fatty liver disease to the burden of liver-related morbidity and mortality, Gastroenterology, 150, 1778, 10.1053/j.gastro.2016.03.005 Jinjuvadia, 2015, Trends in alcoholic hepatitis related hospitalizations, financial burden, and mortality in the United States, J Clin Gastroenterol, 49, 506, 10.1097/MCG.0000000000000161 Haflidadottir, 2014, Long-term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease, BMC Gastroenterol, 14, 166, 10.1186/1471-230X-14-166 Targher, 2016, Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis, J Hepatol, 65, 589, 10.1016/j.jhep.2016.05.013 Toshikuni, 2014, Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease, World J Gastroenterol, 20, 8393, 10.3748/wjg.v20.i26.8393 Ryu, 2015, Age at menarche and non-alcoholic fatty liver disease, J Hepatol, 62, 1164, 10.1016/j.jhep.2014.11.041 Kwon, 2003, Payment system reform for health care providers in Korea, Health Policy Plan, 18, 84, 10.1093/heapol/18.1.84 Park, 2008, Alcohol consumption and the CAGE questionnaire in Korean adults: results from the Second Korea National Health and Nutrition Examination Survey, J Korean Med Sci, 23, 199, 10.3346/jkms.2008.23.2.199 Craig, 2003, International physical activity questionnaire: 12-country reliability and validity, Med Sci Sports Exerc, 35, 1381, 10.1249/01.MSS.0000078924.61453.FB Ahn, 2007, Validation and reproducibility of food frequency questionnaire for Korean genome epidemiologic study, Eur J Clin Nutr, 61, 1435, 10.1038/sj.ejcn.1602657 2000 Kim, 2014, 2014 clinical practice guidelines for overweight and obesity in Korea, Endocrinol Metab (Seoul), 29, 405, 10.3803/EnM.2014.29.4.405 Mathiesen, 2002, Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases, Dig Liver Dis, 34, 516, 10.1016/S1590-8658(02)80111-6 McPherson, 2010, Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease, Gut, 59, 1265, 10.1136/gut.2010.216077 Shah, 2009, Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease, Clin Gastroenterol Hepatol, 7, 1104, 10.1016/j.cgh.2009.05.033 Naveau, 2009, Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease, Hepatology, 49, 97, 10.1002/hep.22576 Sheron, 2019, Alcohol drinking patterns and risk of liver disease in women, Lancet Public Health, 4, e6, 10.1016/S2468-2667(18)30241-X Wai, 2003, A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C, Hepatology, 38, 518, 10.1053/jhep.2003.50346 Lombardi, 2015, Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease, World J Gastroenterol, 21, 11044, 10.3748/wjg.v21.i39.11044 Deleuran, 2012, Cirrhosis and mortality risks of biopsy-verified alcoholic pure steatosis and steatohepatitis: a nationwide registry-based study, Aliment Pharmacol Ther, 35, 1336, 10.1111/j.1365-2036.2012.05091.x Dam-Larsen, 2009, Final results of a long-term, clinical follow-up in fatty liver patients, Scand J Gastroenterol, 44, 1236, 10.1080/00365520903171284 Armstrong, 2014, Extrahepatic complications of nonalcoholic fatty liver disease, Hepatology, 59, 1174, 10.1002/hep.26717 Francque, 2016, Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications, J Hepatol, 65, 425, 10.1016/j.jhep.2016.04.005 Gologorsky, 2013, Coronary artery disease and its risk factors in patients presenting for liver transplantation, J Clin Anesth, 25, 618, 10.1016/j.jclinane.2013.06.001 Patel, 2011, Comparison of the frequency of coronary artery disease in alcohol-related versus non-alcohol-related endstage liver disease, Am J Cardiol, 108, 1552, 10.1016/j.amjcard.2011.07.013 Kim, 2011, Carotid intima-media thickness is increased not only in non-alcoholic fatty liver disease patients but also in alcoholic fatty liver patients, Digestion, 84, 149, 10.1159/000326854 Bellentani, 2000, Prevalence of and risk factors for hepatic steatosis in Northern Italy, Ann Intern Med, 132, 112, 10.7326/0003-4819-132-2-200001180-00004 Greuter, 2017, Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis, JCI Insight, 2, 10.1172/jci.insight.95354 Fernandez-Sola, 2015, Cardiovascular risks and benefits of moderate and heavy alcohol consumption, Nat Rev Cardiol, 12, 576, 10.1038/nrcardio.2015.91 Rehm, 2017, Cardiovascular effects of alcohol consumption, Trends Cardiovasc Med, 27, 534, 10.1016/j.tcm.2017.06.002 Zhao, 2017, Alcohol consumption and mortality from coronary heart disease: an updated meta-analysis of cohort studies, J Stud Alcohol Drugs, 78, 375, 10.15288/jsad.2017.78.375 Karlamangla, 2006, Longitudinal trajectories of heavy drinking in adults in the United States of America, Addiction, 101, 91, 10.1111/j.1360-0443.2005.01299.x Zhang, 2008, Secular trends in alcohol consumption over 50 years: the Framingham Study, Am J Med, 121, 695, 10.1016/j.amjmed.2008.03.013 Li, 2016, Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies, Obes Rev, 17, 510, 10.1111/obr.12407 Berzigotti, 2011, Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis, Hepatology, 54, 555, 10.1002/hep.24418 Machado, 2016, Obesity paradox in cirrhosis: is it real or just an illusion?, Liver Int, 36, 1412, 10.1111/liv.13154 Chang, 2019, Alcoholic and nonalcoholic fatty liver disease and liver-related mortality: a cohort study, Am J Gastroenterol, 114, 620, 10.14309/ajg.0000000000000074 Sinclair, 2016, Review article: sarcopenia in cirrhosis--aetiology, implications and potential therapeutic interventions, Aliment Pharmacol Ther, 43, 765, 10.1111/apt.13549 Lee, 2007, Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center, J Hepatol, 47, 239, 10.1016/j.jhep.2007.02.007 Hernaez, 2011, Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis, Hepatology, 54, 1082, 10.1002/hep.24452 Ballestri, 2017, Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases, Metabolism, 72, 57, 10.1016/j.metabol.2017.04.003 Musso, 2011, Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity, Ann Med, 43, 617, 10.3109/07853890.2010.518623 Kim, 2017, Towards actualizing the value potential of Korea health insurance review and assessment (HIRA) data as a resource for health research: strengths, limitations, applications, and strategies for optimal use of HIRA data, J Korean Med Sci, 32, 718, 10.3346/jkms.2017.32.5.718 Park, 2003 Desai, 2018, Geographic variability in liver disease-related mortality rates in the United States, Am J Med, 131, 728, 10.1016/j.amjmed.2018.01.047 Schultz, 2018, Socioeconomic status and cardiovascular outcomes: challenges and interventions, Circulation, 137, 2166, 10.1161/CIRCULATIONAHA.117.029652 Winkleby, 1992, Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease, Am J Public Health, 82, 816, 10.2105/AJPH.82.6.816